{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:33:28Z","timestamp":1791297208954,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31NS066684"],"award-info":[{"award-number":["F31NS066684"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS054272"],"award-info":[{"award-number":["NS054272"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.expneurol.2011.02.012","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T04:30:17Z","timestamp":1298435417000},"page":"288-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats"],"prefix":"10.1016","volume":"229","author":[{"given":"Kristin B.","family":"Dupre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne Y.","family":"Ostock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Eskow Jaunarajs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Button","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.02.012_bb0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/syn.20195","article-title":"Effects of sarizotan on the corticostriatal glutamate pathways","volume":"58","author":"Antonelli","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0015","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.20370","article-title":"Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease","volume":"20","author":"Bara-Jimenez","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1046\/j.1460-9568.2003.02795.x","article-title":"The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis","volume":"18","author":"Bianchi","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.expneurol.2005.08.017","article-title":"Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD","volume":"196","author":"Bibbiani","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0030","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/j.1460-9568.2006.04790.x","article-title":"MDMA and fenfluramine reduce l-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation","volume":"23","author":"Bishop","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0035","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jnr.21978","article-title":"Contribution of the striatum to the effects of 5-HT1A receptor stimulation in l-DOPA-treated hemiparkinsonian rats","volume":"87","author":"Bishop","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neuroscience.2009.12.032","article-title":"Site-specific action of L-3, 4-dihydroxyphenylalanine in the striatum but not globus pallidus and substantia nigra pars reticulata evokes dyskinetic movements in chronic L-3, 4-dihydroxyphenylalanine-treated 6-hydroxydopamine-lesioned rats","volume":"166","author":"Buck","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0278-5846(01)00237-8","article-title":"Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated monkeys following dopamine agonist treatment","volume":"26","author":"Calon","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuroscience.2005.09.024","article-title":"Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat","volume":"137","author":"Campbell","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0055","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1523\/JNEUROSCI.0252-10.2010","article-title":"Striatal overexpression of \u0394FosB reproduces chronic levodopa-induced involuntary movements","volume":"30","author":"Cao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00213-004-1917-4","article-title":"The 5-HT1A receptor and behavioral stimulation in the rat: Effects of 8-OHDPAT on spontaneous and cocaine-induced behavior","volume":"177","author":"Carey","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0065","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.expneurol.2010.04.016","article-title":"Dyskinetic potential of dopamine agonists is associated with different striatonigral\/striatopallidal zif-268 expression","volume":"224","author":"Carta","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","article-title":"Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia","volume":"30","author":"Cenci","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0080","first-page":"2694","article-title":"l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0085","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1471-1931(00)00018-5","article-title":"Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism","volume":"23","author":"Chase","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01352-9","article-title":"Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats","volume":"464","author":"Corsi","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","article-title":"Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model","volume":"179","author":"Dekundy","year":"2007","journal-title":"Beh. Brain Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0100","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.npp.1301329","article-title":"Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging","volume":"32","author":"Delfino","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0105","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0024-3205(88)90267-6","article-title":"An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates","volume":"43","author":"Donzanti","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainres.2007.05.005","article-title":"The differential effects of 5-HT1A receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat","volume":"1158","author":"Dupre","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0115","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.neuropharm.2008.08.031","article-title":"Striatal 5-HT1A receptor stimulation reduced D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat","volume":"55","author":"Dupre","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-008-1135-6","article-title":"Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on l-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat","volume":"199","author":"Dupre","year":"2008","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pbb.2007.05.002","article-title":"The partial 5-HT1A agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy","volume":"87","author":"Eskow","year":"2007","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0130","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/syn.20630","article-title":"The role of the dorsal raphe nucleus in the development, expression, and treatment of LID in hemiparkinsonian rats","volume":"63","author":"Eskow","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(94)90099-X","article-title":"Motor activation in short- and long-term reserpinized mice: role of N-methyl-d-aspartate, dopamine D1 and dopamine D2 receptors","volume":"255","author":"Ferr\u00e9","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0140","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2\/MAP kinase","volume":"22","author":"Gerfen","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0145","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1523\/JNEUROSCI.3952-07.2008","article-title":"Differences between dorsal and ventral striatum in drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase","volume":"28","author":"Gerfen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.21226","article-title":"Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF00216019","article-title":"The pharmacology of the behavioral and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)","volume":"91","author":"Goodwin","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02257618","article-title":"Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801","volume":"4","author":"Goodwin","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0165","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nbd.2007.02.001","article-title":"Altered D1 dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates","volume":"26","author":"Guigoni","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(97)13443-7","article-title":"Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors","volume":"224","author":"Hu","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0175","article-title":"Regulation of cortical and striatal 5-HT(1A) receptors in the MPTP-lesioned macaque","author":"Huot","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0180","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1124\/jpet.106.110429","article-title":"In 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist(R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with increased motor disability","volume":"319","author":"Iravani","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0185","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20458","article-title":"Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations","volume":"20","author":"Jankovic","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(01)03147-X","article-title":"MK801 suppresses the l-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats","volume":"926","author":"Jonkers","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0195","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1471-4159.1986.tb08506.x","article-title":"A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: An isocratic HPLC technique employing coulometric detection and minimal sample preparation","volume":"46","author":"Kilpatrick","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1471-4159.2010.06776.x","article-title":"Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease","volume":"114","author":"Kobylecki","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0304-3940(90)90463-J","article-title":"Bilateral regulation of glutamate tissue and extracellular levels in caudate\u2013putamen by midbrain dopamine neurons","volume":"115","author":"Lindefors","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0210","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","article-title":"l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia","volume":"112","author":"Lindgren","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(96)00693-2","article-title":"MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats","volume":"736","author":"Marin","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2006.07.003","article-title":"Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions","volume":"1112","author":"Matsubara","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(98)00189-4","article-title":"Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion","volume":"88","author":"Meshul","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-002-1121-3","article-title":"Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat","volume":"163","author":"Mignon","year":"2002","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00001756-200505120-00009","article-title":"8-Hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease","volume":"16","author":"Mignon","year":"2005","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0245","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2008.10.007","article-title":"Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55, 212-2","volume":"54","author":"Morgese","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0250","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1523\/JNEUROSCI.20-20-07782.2000","article-title":"A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease","volume":"20","author":"Nash","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0255","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neuroscience.2010.03.022","article-title":"Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias","volume":"167","author":"Ouattara","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0260","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1212\/01.wnl.0000242888.30755.5d","article-title":"Clinical correlates of levodopa-induced dopamine release in Parkinson disease","volume":"67","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0265","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0270","series-title":"Nonparametric Statistics for Health Care Research: Statistics for Small Samples and Unusual Distributions","author":"Pett","year":"1997"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0275","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(99)00338-3","article-title":"Prior dopamine D1 receptor stimulation is required to prime D2-mediated striatal fos expression in 6-hydroxydopamine-lesioned rats","volume":"94","author":"Pollack","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0280","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/j.1460-9568.1995.tb00640.x","article-title":"Dopamine\u2013glutamate\u2013GABA interactions and ageing: studies in the striatum of the conscious rat","volume":"7","author":"Porras","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0285","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1523\/JNEUROSCI.18-06-02009.1998","article-title":"Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata","volume":"18","author":"Radnikow","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0290","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neuropharm.2008.06.002","article-title":"6-OHDA-induced hemiparkinsonism and chronic l-DOPA treatment increase dopamine D1-stimulated [3H]-GABA release and [3H]-cAMP production in substantia nigra pars reticulata of the rat","volume":"55","author":"Rangel-Barajas","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0295","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archneur.58.2.249","article-title":"Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease","volume":"58","author":"Rascol","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0300","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/mds.20988","article-title":"Development of dyskinesias in a 5-year trial of ropinirole and l-dopa","volume":"21","author":"Rascol","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0305","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1748-1716.1990.tb09030.x","article-title":"Striatal dopamine and glutamate release: effects of intranigral injections of substance P","volume":"140","author":"Reid","year":"1990","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0310","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1460-9568.2004.03591.x","article-title":"Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease","volume":"20","author":"Robelet","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0315","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-4886(02)00050-X","article-title":"Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function","volume":"180","author":"Robinson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-0270(94)00132-Z","article-title":"Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatisation","volume":"57","author":"Rowley","year":"1995","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0325","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 antagonist under clinical development improves l-DOPA-induced dyskinesia in parkinsonian rats and monkeys","volume":"39","author":"Rylander","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0330","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuropharm.2005.12.004","article-title":"Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not l-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat","volume":"50","author":"Taylor","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0335","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neures.2005.03.004","article-title":"A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to l-DOPA in a rodent model of Parkinson's disease","volume":"52","author":"Tomiyama","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0340","first-page":"243","article-title":"Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1\/D2 coactivation induces potentiated responses","volume":"405","author":"Weick","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0345","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of l-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2011.02.012_bb0350","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-4159.1992.tb10048.x","article-title":"Dopaminergic modulation of glutamate release in striatum as measured by microdialysis","volume":"58","author":"Yamamoto","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0355","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2006.09.027","article-title":"Subchronic administration of l-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata","volume":"1123","author":"Yamamoto","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.02.012_bb0360","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0924-977X(96)00395-1","article-title":"Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat","volume":"7","author":"Yu","year":"1997","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:46:07Z","timestamp":1762148767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0014488611000604"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.02.012","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}